Posted by Michael Wonder on 08 Oct 2024
The FDA approved a self-administered nasal spray for the flu. Here’s how it compares to the traditional flu shot.
6 October 2024 - The US FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent Influenza disease. The nasal spray prevents the flu from Influenza virus sub-types A and B in individuals between the ages of 2 and 49.
FluMist can now be administered by a healthcare provider at a pharmacy, or even self-administered by adults at the comfort of their homes.
